BNP Paribas Financial Markets’s Agilon Health AGL Stock Holding History

BNP Paribas Financial Markets’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Buy	25,780 +21,546	+509%	+$348K	﹤0.01%	4040
2025 Q4	$72.9K	Sell	4,234 -50,891	-92%	-$987K	﹤0.01%	4515
2025 Q3	$1.42M	Buy	55,125 +53,531	+3,358%	+$2.02M	﹤0.01%	2873
2025 Q2	$91.7K	Sell	1,594 -389	-20%	-$31.2K	﹤0.01%	4052
2025 Q1	$215K	Sell	1,983 -11,829	-86%	-$1.03M	﹤0.01%	3650
2024 Q4	$656K	Buy	+13,812	New	+$835K	﹤0.01%	3102
2022 Q4	–	Sell	-847	Closed	-$496K	–	4045
2022 Q3	$496K	Buy	+847	New	+$507K	﹤0.01%	2985

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

BNP Paribas Financial Markets's AGL Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Agilon Health (AGL) stake by 509% in Q1 2026, buying an estimated $348K and bringing the position to 25,780 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

BNP Paribas Financial Markets first reported a position in AGL in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.42M in Q3 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

BNP Paribas Financial Markets held 25,780 shares of Agilon Health worth $204K as of Q1 2026.
BNP Paribas Financial Markets bought 21,546 Agilon Health shares in Q1 2026, an estimated $348K.
Agilon Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4040 holding.
BNP Paribas Financial Markets first reported a position in Agilon Health in Q3 2022 and has held it in 7 quarters since.
BNP Paribas Financial Markets's Agilon Health position peaked at $1.42M in Q3 2025.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.